Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2019-01-01
2020-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A second aim of the study is to assess the safety and tolerability of mineral clay masks by assessing redness and participant feedback.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Four Topical Products to Improve Skin Longevity
NCT07118943
The Effects of Microdermabrasion on Skin Remodeling
NCT00111254
Evaluation of the Efficacy and Tolerance of a Light Therapy Mask on Mild to Moderate Brown Spots and Moderate to Severe Facial Wrinkles
NCT03312543
Topical Centella Asiatica and the Cosmetic Appearance of Stretch Marks
NCT02601105
The Effect of Topical Almond Oil vs. Topical Retinol on The Appearance of Facial Wrinkles
NCT05011461
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
French Green Clay Mask
Clay mask
Clay mask powders- French green, Rhassul and bentonite
Rhassoul Clay Mask
Clay mask
Clay mask powders- French green, Rhassul and bentonite
Bentonite Clay Mask
Clay mask
Clay mask powders- French green, Rhassul and bentonite
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clay mask
Clay mask powders- French green, Rhassul and bentonite
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals in good general health
* Individuals free of any autoimmune or systemic disorder, which would interfere with the analysis.
Exclusion Criteria
* Individuals who have history of acute or chronic disease that would likely interfere with or increase the risk on study participation at the discretion of the investigator
* Individuals with active (flaring) disease or chronic skin allergies (atopic dermatitis/eczema) or those who have recently undergone treatment for skin cancer (within the last 12 months) in the area of testing on the forehead, nose and the cheeks
* Female volunteers who are pregnant or planning to become pregnant over the course of the study. The risk to pregnant women is minimal but the facial appearance can be confounded by the altered hormones associated with pregnancy, as is well documented in chloasma which is dyspigmentation that arises in pregnancy. Women who become pregnant during the duration of the study will become ineligible but there are no birth control requirements.
* Female volunteers who have started a new hormonal birth control agent or switched to a hormonal birth control agent within the past 60 days
* Individuals who have had any medical or cosmetic procedure, such as laser resurfacing, or plastic surgery to the test site (face) within the last 6 months. This includes botulinum toxin, dermal fillers, collagen or other similar cosmetic procedure
* Individuals who are currently using or during the past 14 days have used a retinoid such as tretinoin, adapalene, or retinol containing agents or a hydroquinone containing agent
* Individuals who have used mineral clay masks on their face within the last 14 days
* Individuals with a known history of hypersensitivity to any ingredients to the agent that is being assessed
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California Davis
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1296789
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.